Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5825170, 8 pages
http://dx.doi.org/10.1155/2016/5825170
Review Article

Selective Insulin Resistance in the Kidney

1Department of Internal Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan
2Yaizu City Hospital, 1000 Dobara, Yaizu, Shizuoka 425-8505, Japan

Received 16 February 2016; Revised 4 April 2016; Accepted 7 April 2016

Academic Editor: Denis Feliers

Copyright © 2016 Shoko Horita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. G. Banting, C. H. Best, J. B. Collip, W. R. Campbell, and A. A. Fletcher, “Pancreatic extracts in the treatment of diabetes mellitus,” Canadian Medical Association Journal, vol. 12, no. 3, pp. 141–146, 1922. View at Google Scholar
  2. V. T. Samuel and G. I. Shulman, “Mechanisms for insulin resistance: common threads and missing links,” Cell, vol. 148, no. 5, pp. 852–871, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. J. Hale and R. J. Coward, “The insulin receptor and the kidney,” Current Opinion in Nephrology and Hypertension, vol. 22, pp. 100–106, 2013. View at Google Scholar
  4. L. J. Hale and R. J. M. Coward, “Insulin signalling to the kidney in health and disease,” Clinical Science, vol. 124, no. 6, pp. 351–370, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. F. White, “IRS proteins and the common path to diabetes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 283, no. 3, pp. E413–E422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Gehart, S. Kumpf, A. Ittner, and R. Ricci, “MAPK signalling in cellular metabolism: stress or wellness?” EMBO Reports, vol. 11, no. 11, pp. 834–840, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. Könner and J. C. Brüning, “Selective insulin and leptin resistance in metabolic disorders,” Cell Metabolism, vol. 16, no. 2, pp. 144–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. D. Michael, R. N. Kulkarni, C. Postic et al., “Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction,” Molecular Cell, vol. 6, no. 1, pp. 87–97, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. S. B. Biddinger and C. R. Kahn, “From mice to men: insights into the insulin resistance syndromes,” Annual Review of Physiology, vol. 68, pp. 123–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mima, Y. Ohshiro, M. Kitada et al., “Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity,” Kidney International, vol. 79, no. 8, pp. 883–896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Nakamura, O. Yamazaki, A. Shirai et al., “Preserved Na/HCO3 cotransporter sensitivity to insulin may promote hypertension in metabolic syndrome,” Kidney International, vol. 87, no. 3, pp. 535–542, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Nakamura, D. S. Emmanouel, and A. I. Katz, “Insulin binding sites in various segments of the rabbit nephron,” The Journal of Clinical Investigation, vol. 72, no. 1, pp. 388–392, 1983. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Wu, K. Chen, and K. J. Williams, “The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia,” Current Opinion in Lipidology, vol. 23, no. 4, pp. 334–344, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Bakan and M. Laplante, “Connecting mTORC1 signaling to SREBP-1 activation,” Current Opinion in Lipidology, vol. 23, no. 3, pp. 226–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. T. K. Sin, B. Y. Yung, and P. M. Siu, “Modulation of SIRT1-foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance,” Cellular Physiology and Biochemistry, vol. 35, no. 2, pp. 541–552, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Nakamura, N. Satoh, M. Suzuki et al., “Stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in type 2 diabetes with nephropathy,” Biochemical and Biophysical Research Communications, vol. 461, no. 1, pp. 154–158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Lay and R. J. Coward, “Recent advances in our understanding of insulin signalling to the podocyte,” Nephrology Dialysis Transplantation, vol. 29, no. 6, pp. 1127–1133, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Santamaria, E. Marquez, A. Lay et al., “IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1853, no. 12, pp. 3224–3234, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Sun, S. Liu, S. Ferguson et al., “Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice,” The Journal of Biological Chemistry, vol. 277, no. 26, pp. 23301–23307, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Taniguchi, K. Ueki, and C. R. Kahn, “Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 718–727, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Zhang, Y. Nakatsu, T. Shinjo et al., “Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1,” The Journal of Biological Chemistry, vol. 288, no. 28, pp. 20692–20701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Matsumoto, S. Han, T. Kitamura, and D. Accili, “Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism,” The Journal of Clinical Investigation, vol. 116, no. 9, pp. 2464–2472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Gonzalez, E. Flier, D. Molle, D. Accili, and T. E. McGraw, “Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 25, pp. 10162–10167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. B. D. Manning and L. C. Cantley, “AKT/PKB signaling: navigating downstream,” Cell, vol. 129, no. 7, pp. 1261–1274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Matsumoto, W. Ogawa, K. Teshigawara et al., “Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes,” Diabetes, vol. 51, no. 6, pp. 1672–1680, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Shimomura, M. Matsuda, R. E. Hammer, Y. Bashmakov, M. S. Brown, and J. L. Goldstein, “Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice,” Molecular Cell, vol. 6, no. 1, pp. 77–86, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Landis and L. M. Shaw, “Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis,” The Journal of Biological Chemistry, vol. 289, no. 26, pp. 18603–18613, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. B. Biddinger, A. Hernandez-Ono, C. Rask-Madsen et al., “Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis,” Cell Metabolism, vol. 7, no. 2, pp. 125–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. S. Brown and J. L. Goldstein, “Selective versus total insulin resistance: a pathogenic paradox,” Cell Metabolism, vol. 7, no. 2, pp. 95–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Laplante and D. M. Sabatini, “mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3281–3282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. J. Gumucio, “Hepatocyte heterogeneity: the coming of age from the description of a biological curiosity to a partial understanding of its physiological meaning and regulation,” Hepatology, vol. 9, no. 1, pp. 154–160, 1989. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Guzman and J. Castro, “Zonation of fatty acid metabolism in rat liver,” Biochemical Journal, vol. 264, no. 1, pp. 107–113, 1989. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Jungermann and T. Kietzmann, “Zonation of parenchymal and nonparenchymal metabolism in liver,” Annual Review of Nutrition, vol. 16, pp. 179–203, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Postic and J. Girard, “Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice,” The Journal of Clinical Investigation, vol. 118, no. 3, pp. 829–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Braeuning, C. Ittrich, C. Köhle et al., “Differential gene expression in periportal and perivenous mouse hepatocytes,” FEBS Journal, vol. 273, no. 22, pp. 5051–5061, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. N. R. Katz, “Metabolic heterogeneity of hepatocytes across the liver acinus,” The Journal of Nutrition, vol. 122, no. 3, pp. 843–849, 1992. View at Google Scholar · View at Scopus
  37. B. S. Hijmans, A. Grefhorst, M. H. Oosterveer, and A. K. Groen, “Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences,” Biochimie, vol. 96, no. 1, pp. 121–129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Y. Jiang, Y.-W. Lin, A. Clemont et al., “Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats,” The Journal of Clinical Investigation, vol. 104, no. 4, pp. 447–457, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Kuboki, Z. Y. Jiang, N. Takahara et al., “Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin,” Circulation, vol. 101, no. 6, pp. 676–681, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Montagnani, H. Chen, V. A. Barr, and M. J. Quon, “Insulin-stimulated Activation of eNOS Is Independent of Ca2+ but Requires Phosphorylation by Akt at Ser1179,” The Journal of Biological Chemistry, vol. 276, no. 32, pp. 30392–30398, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Federici, A. Pandolfi, E. A. De Filippis et al., “G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells,” Circulation, vol. 109, no. 3, pp. 399–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Abe, N. Yamada, K. Kamata et al., “Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1,” The Journal of Clinical Investigation, vol. 101, no. 8, pp. 1784–1788, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Kubota, N. Kubota, M. Moroi et al., “Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury,” Circulation, vol. 107, no. 24, pp. 3073–3080, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Rask-Madsen and G. L. King, “Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 1, pp. 46–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Rask-Madsen, Q. Li, B. Freund et al., “Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice,” Cell Metabolism, vol. 11, no. 5, pp. 379–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Cusi, K. Maezono, A. Osman et al., “Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle,” The Journal of Clinical Investigation, vol. 105, no. 3, pp. 311–320, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. L. J. Goodyear, F. Giorgino, L. A. Sherman, J. Carey, R. J. Smith, and G. L. Dohm, “Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects,” The Journal of Clinical Investigation, vol. 95, no. 5, pp. 2195–2204, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. Y.-B. Kim, S. E. Nikoulina, T. P. Ciaraldi, R. R. Henry, and B. B. Kahn, “Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes,” The Journal of Clinical Investigation, vol. 104, no. 6, pp. 733–741, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Huang, A. C. P. Thirone, X. Huang, and A. Klip, “Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in L6 myotubes,” The Journal of Biological Chemistry, vol. 280, no. 19, pp. 19426–19435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. C. P. Thirone, C. Huang, and A. Klip, “Tissue-specific roles of IRS proteins in insulin signaling and glucose transport,” Trends in Endocrinology and Metabolism, vol. 17, no. 2, pp. 72–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Agarwal, R. Srivastava, A. K. Srivastava, S. Ali, and M. Datta, “MiR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1832, no. 8, pp. 1294–1303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Pirola, S. Bonnafous, A. M. Johnston, C. Chaussade, F. Portis, and E. Van Obberghen, “Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells,” The Journal of Biological Chemistry, vol. 278, no. 18, pp. 15641–15651, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Ueki, T. Kondo, and C. R. Kahn, “Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms,” Molecular and Cellular Biology, vol. 24, no. 12, pp. 5434–5446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Renström, J. Burén, M. Svensson, and J. W. Eriksson, “Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes,” Metabolism: Clinical and Experimental, vol. 56, no. 2, pp. 190–198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Anai, H. Ono, M. Funaki et al., “Different subcellular distribution and regulation of expression of insulin receptor substrate (IRS)-3 from those of IRS-1 and IRS-2,” The Journal of Biological Chemistry, vol. 273, no. 45, pp. 29686–29692, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Renström, J. Burén, and J. W. Eriksson, “Insulin receptor substrates-1 and -2 are both depleted but via different mechanisms after down-regulation of glucose transport in rat adipocytes,” Endocrinology, vol. 146, no. 7, pp. 3044–3051, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Marette, J. M. Richardson, T. Ramlal et al., “Abundance, localization, and insulin-induced translocation of glucose transporters in red and white muscle,” American Journal of Physiology—Cell Physiology, vol. 263, no. 2, pp. C443–C452, 1992. View at Google Scholar · View at Scopus
  58. S. Satoh, H. Nishimura, A. E. Clark et al., “Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone action,” The Journal of Biological Chemistry, vol. 268, no. 24, pp. 17820–17829, 1993. View at Google Scholar · View at Scopus
  59. M. J. Quon, A. J. Butte, M. J. Zarnowski, G. Sesti, S. W. Cushman, and S. I. Taylor, “Insulin receptor substrate 1 mediates the stimulatory effect of insulin on GLUT4 translocation in transfected rat adipose cells,” The Journal of Biological Chemistry, vol. 269, no. 45, pp. 27920–27924, 1994. View at Google Scholar · View at Scopus
  60. B. Gustafson, S. Gogg, S. Hedjazifar, L. Jenndahl, A. Hammarstedt, and U. Smith, “Inflammation and impaired adipogenesis in hypertrophic obesity in man,” American Journal of Physiology—ndocrinology and Metabolism, vol. 297, no. 5, pp. E999–E1003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Gustafson, A. Hammarstedt, C. X. Andersson, and U. Smith, “Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2276–2283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. S. S. Thomas, L. Zhang, and W. E. Mitch, “Molecular mechanisms of insulin resistance in chronic kidney disease,” Kidney International, vol. 88, no. 6, pp. 1233–1239, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. R. A. DeFronzo, A. Alvestrand, D. Smith, R. Hendler, E. Hendler, and J. Wahren, “Insulin resistance in uremia,” The Journal of Clinical Investigation, vol. 67, no. 2, pp. 563–568, 1981. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Fliser, G. Pacini, R. Engelleiter et al., “Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease,” Kidney International, vol. 53, no. 5, pp. 1343–1347, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Almquist, S. H. Jacobson, F. Mobarrez, P. Näsman, and P. Hjemdahl, “Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease,” European Journal of Clinical Investigation, vol. 44, no. 3, pp. 276–284, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. C. L. Meuwese, S. Snaedal, N. Halbesma et al., “Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 26, no. 4, pp. 1313–1318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. B. J. G. Pereira, S. Sundaram, B. Snodgrass, P. Hogan, and A. J. King, “Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients,” Journal of the American Society of Nephrology, vol. 7, no. 3, pp. 479–487, 1996. View at Google Scholar · View at Scopus
  68. J. E. Friedman, G. L. Dohm, C. W. Elton et al., “Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors,” American Journal of Physiology—Endocrinology and Metabolism, vol. 261, no. 1, pp. E87–E94, 1991. View at Google Scholar · View at Scopus
  69. D. Smith and R. A. DeFronzo, “Insulin resistance in uremia mediated by postbinding defects,” Kidney International, vol. 22, no. 1, pp. 54–62, 1982. View at Publisher · View at Google Scholar · View at Scopus
  70. S. H. Lecker, A. L. Goldberg, and W. E. Mitch, “Protein degradation by the ubiquitin-proteasome pathway in normal and disease states,” Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 1807–1819, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. W. E. Mitch and A. L. Goldberg, “Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway,” The New England Journal of Medicine, vol. 335, no. 25, pp. 1897–1905, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Natali, A. Quinones Galvan, D. Santoro et al., “Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man,” Clinical Science, vol. 85, no. 3, pp. 327–335, 1993. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Quiñones-Galvan and E. Ferrannini, “Renal effects of insulin in man,” Journal of Nephrology, vol. 10, no. 4, pp. 188–191, 1997. View at Google Scholar · View at Scopus
  74. M. Baum, “Insulin stimulates volume absorption in the rabbit proximal convoluted tubule,” The Journal of Clinical Investigation, vol. 79, no. 4, pp. 1104–1109, 1987. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Feraille, M. L. Carranza, M. Rousselot, and H. Favre, “Insulin enhances sodium sensitivity of Na-K-ATPase in isolated rat proximal convoluted tubule,” American Journal of Physiology, vol. 267, no. 1, part 2, pp. F55–F62, 1994. View at Google Scholar · View at Scopus
  76. F. A. Gesek and A. C. Schoolwerth, “Insulin increases Na+-H+ exchange activity in proximal tubules from normotensive and hypertensive rats,” American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 260, no. 5, pp. F695–F703, 1991. View at Google Scholar · View at Scopus
  77. O. S. Ruiz, Y.-Y. Qiu, L. R. Cardoso, and J. A. L. Arruda, “Regulation of the renal Na-HCO3 cotransporter: IX. Modulation by insulin, epidermal growth factor and carbachol,” Regulatory Peptides, vol. 77, no. 1–3, pp. 155–161, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. O. Ito, Y. Kondo, N. Takahashi et al., “Insulin stimulates NaCl transport in isolated perfused MTAL of Henle's loop of rabbit kidney,” American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 267, no. 2, pp. F265–F270, 1994. View at Google Scholar · View at Scopus
  79. B. Mandon, E. Siga, D. Chabardes, D. Firsov, N. Roinel, and C. De Rouffignac, “Insulin stimulates Na+, Cl-, Ca2+, and Mg2+ transports in TAL of mouse nephron: cross-potentiation with AVP,” American Journal of Physiology—Renal Physiology, vol. 265, no. 3, part 2, pp. F361–F369, 1993. View at Google Scholar
  80. E. Sohara, T. Rai, S.-S. Yang et al., “Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney,” PLoS ONE, vol. 6, no. 8, Article ID e24277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Feraille, M. Rousselot, R. Rajerison, and H. Favre, “Effect of insulin on Na+,K(+)-ATPase in rat collecting duct,” The Journal of Physiology, vol. 488, no. 1, pp. 171–180, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Zheng, H. Yamada, K. Sakamoto et al., “Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption,” Journal of the American Society of Nephrology, vol. 16, no. 8, pp. 2288–2295, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Nishida, E. Sohara, N. Nomura et al., “Phosphatidylinositol 3-kinase/akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice,” Hypertension, vol. 60, no. 4, pp. 981–990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. V. Papademetriou, L. Lovato, M. Doumas et al., “Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes,” Kidney International, vol. 87, no. 3, pp. 649–659, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. R. Gatica, R. Bertinat, P. Silva et al., “Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney,” Journal of Cellular Biochemistry, vol. 114, no. 3, pp. 639–649, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. J. E. Gerich, H. J. Woerle, C. Meyer, and M. Stumvoll, “Renal gluconeogenesis: its importance in human glucose homeostasis,” Diabetes Care, vol. 24, no. 2, pp. 382–391, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Meyer, M. Stumvoll, V. Nadkarni, J. Dostou, A. Mitrakou, and J. Gerich, “Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus,” The Journal of Clinical Investigation, vol. 102, no. 3, pp. 619–624, 1998. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Meyer, H. J. Woerle, J. M. Dostou, S. L. Welle, and J. E. Gerich, “Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 287, no. 6, pp. E1049–E1056, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. H. G. Bohlen, “Protein kinase βII in Zucker obese rats compromises oxygen and flow-mediated regulation of nitric oxide formation,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 286, no. 2, pp. H492–H497, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. K. Naruse, C. Rask-Madsen, N. Takahara et al., “Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance,” Diabetes, vol. 55, no. 3, pp. 691–698, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. E. Y. Kim, M. Anderson, and S. E. Dryer, “Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species,” American Journal of Physiology—Renal Physiology, vol. 302, no. 3, pp. F298–F307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. E. Y. Kim and S. E. Dryer, “Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes,” Journal of Cellular Physiology, vol. 226, no. 9, pp. 2307–2315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. G. I. Welsh, L. J. Hale, V. Eremina et al., “Insulin signaling to the glomerular podocyte is critical for normal kidney function,” Cell Metabolism, vol. 12, no. 4, pp. 329–340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. D. R. Alessi and C. P. Downes, “The role of PI 3-kinase in insulin action,” Biochimica et Biophysica Acta—Lipids and Lipid Metabolism, vol. 1436, no. 1-2, pp. 151–164, 1998. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Khwaja, “Apoptosis: Akt is more than just a bad kinase,” Nature, vol. 401, no. 6748, pp. 33–34, 1999. View at Publisher · View at Google Scholar · View at Scopus
  96. S. F. Knight and J. D. Imig, “Obesity, insulin resistance, and renal function,” Microcirculation, vol. 14, no. 4-5, pp. 349–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Canaud, F. Bienaimé, A. Viau et al., “AKT2 is essential to maintain podocyte viability and function during chronic kidney disease,” Nature Medicine, vol. 19, no. 10, pp. 1288–1296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Bjornstad, J. K. Snell-Bergeon, M. Rewers et al., “Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes,” Diabetes Care, vol. 36, no. 11, pp. 3678–3683, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. T. J. Orchard, Y.-F. Chang, R. E. Ferrell, N. Petro, and D. E. Ellis, “Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study,” Kidney International, vol. 62, no. 3, pp. 963–970, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Pop, D. Clenciu, M. Anghel et al., “Insulin resistance is associated with all chronic complications in type 1 diabetes,” Journal of Diabetes, vol. 8, pp. 220–228, 2016. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Lee, W. Kim, K. P. Kang et al., “Agonist of peroxisome proliferator-activated receptor-γ, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model,” Nephrology Dialysis Transplantation, vol. 20, pp. 1057–1065, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Sivarajah, P. K. Chatterjee, N. S. A. Patel et al., “Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury,” American Journal of Nephrology, vol. 23, no. 4, pp. 267–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. H.-C. Yang, S. Deleuze, Y. Zuo, S. A. Potthoff, L.-J. Ma, and A. B. Fogo, “The PPARγ agonist pioglitazone ameliorates aging-related progressive renal injury,” Journal of the American Society of Nephrology, vol. 20, no. 11, pp. 2380–2388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Endo, M. Suzuki, H. Yamada et al., “Thiazolidinediones enhance sodium-coupled bicarbonate absorption from renal proximal tubules via PPARγ-dependent nongenomic signaling,” Cell Metabolism, vol. 13, no. 5, pp. 550–561, 2011. View at Publisher · View at Google Scholar · View at Scopus